Share the post "Nath Biogene India Ltd.’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales decreased by 4.33 % in YoY and increased by 35.6 % in QoQ"
Highlights
- Sales over the Year and quarter: The company’s sales declined by -4.33 % over the year, substantial increase in net sales/revenue by 35.6 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -74.27 %, Marginal increase in other income during this quarter, up by 1000%.
- Profit over the Year and quarter: Significant improvement in profitability for Nath Biogene India Ltd.. Notable increase of 120.94 % in net profit Year to Year, Nath Biogene India Ltd.’s profitability dropped by -18.93 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 159.52 % Year to Year. EPS increased by 4.31 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 44.988 Cr | Rs. 31.738 Cr | Rs. 43.038 Cr | + 35.6 % | -4.33 % |
| Expenses | Rs. 41.06 Cr | Rs. 25.95 Cr | Rs. 38.56 Cr | + 48.59 % | -6.09 % |
| Operating Profit | Rs. 3.93 Cr | Rs. 5.79 Cr | Rs. 4.48 Cr | -22.63 % | + 13.99 % |
| OPM % | 8.74 % | 18.24 % | 10.41 % | -7.83 % | + 1.67 % |
| Other Income | Rs. 1.71 Cr | Rs. 0.04 Cr | Rs. 0.44 Cr | + 1000 % | -74.27 % |
| Interest | Rs. 1.53 Cr | Rs. 2.84 Cr | Rs. 1.06 Cr | -62.68 % | -30.72 % |
| Depreciation | Rs. 0.99 Cr | Rs. 0.76 Cr | Rs. 0.98 Cr | + 28.95 % | -1.01 % |
| Profit before tax | Rs. 3.12 Cr | Rs. 2.23 Cr | Rs. 2.88 Cr | + 29.15 % | -7.69 % |
| Tax % | 13.85 % | 16.22 % | 16.09 % | -0.13 % | + 2.24 % |
| Net Profit | Rs. 1.45 Cr | Rs. 3.96 Cr | Rs. 3.21 Cr | -18.94 % | + 121.38 % |
| EPS in Rs | Rs. 0.84 | Rs. 2.09 | Rs. 2.18 | + 4.31 % | + 159.52 % |
Today, we’re looking at Nath Biogene India Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -4.33 %. However, it did see a marginal increase of 35.6 % from the previous quarter. Expenses ticked up slightly by 48.59 % quarter-on-quarter, aligning with the annual decline of -6.09 %. Operating profit, while up 13.99 % compared to last year, faced a quarter-on-quarter dip of -22.63 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 1.67 %, but a shrinkage of -7.83 % sequentially. Other income rose by 1000 % compared to the last quarter, despite an annual decline of -74.27 %. Interest expenses dropped significantly by -62.68 % from the previous quarter, yet the year-over-year decrease remains at a moderate -30.72 %. Depreciation costs climbed by 28.95 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -1.01 %. Profit before tax declined annually by -7.69 % but saw an increase from the preceding quarter by 29.15 %.
Tax expenses as a percentage of profits increased slightly by 2.24 % compared to last year, with a more notable quarter-on-quarter decrease of -0.13 %. Net profit rose by 121.38 % year-on-year but witnessed a -18.94 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 159.52 % but a quarterly rise of 4.31 %. In summary, Nath Biogene India Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 44.988 Cr | Rs. 31.738 Cr | Rs. 43.038 Cr | + 35.6 % | -4.33 % |
| Expenses | Rs. 41.06 Cr | Rs. 25.95 Cr | Rs. 38.56 Cr | + 48.59 % | -6.09 % |
| Operating Profit | Rs. 3.93 Cr | Rs. 5.79 Cr | Rs. 4.48 Cr | -22.63 % | + 13.99 % |
| Net Profit | Rs. 1.45 Cr | Rs. 3.96 Cr | Rs. 3.21 Cr | -18.94 % | + 121.38 % |
| EPS in Rs | Rs. 0.84 | Rs. 2.09 | Rs. 2.18 | + 4.31 % | + 159.52 % |
In reviewing Nath Biogene India Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -4.33 % year-on-year, however, there was a minor increase of 35.6 % from the previous quarter. Expenses decreased by -6.09 % compared to the previous year, with a 48.59 % increase quarter-on-quarter. Operating Profit surged by 13.99 % annually, and saw a -22.63 % decrease from the last quarter.
Net Profit showed yearly increase of 121.38 %, and experienced a -18.94 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 159.52 % annually, however rose by 4.31 % compared to the last quarter. In essence, while Nath Biogene India Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
